Skip to content

Clinical trials

Phase 1/2 Hematologic Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1/2 Country / region: Israel Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20102
20152
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGC Biologics S.p.A.1
Cellect Biotechnology1
Curis, Inc.1
Hadassah Medical Organization1
Janssen Research & Development, LLC1
Mirror Biologics, Inc.1
Molecular Templates, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms8
Lymphoma3
Lymphoma, Non-Hodgkin3
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Neoplasms2
Recurrence2
Graft vs Host Disease1
Hodgkin Disease1
Immune System Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.